MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

14.01
-0.14
-0.99%
Opening 11:23 05/25 EDT
OPEN
13.99
PREV CLOSE
14.15
HIGH
14.01
LOW
13.83
VOLUME
3.25K
TURNOVER
24.51K
52 WEEK HIGH
32.99
52 WEEK LOW
13.08
TOTAL ASSET
22.46M
YTD YIELD
7.47%
1D
5D
1M
3M
1Y
5Y
Flow Traders Executive Leaves After Swedish Ski Trip Incidents
Bloomberg · 05/10 08:00
Turn Off the Memes, This Party’s Over Like in 2000
Bloomberg · 05/10 04:54
China’s Climate-Focused Funds Surpass U.S. With $47 Billion in Assets
Bloomberg · 05/10 04:09
Cathie Wood’s Famed Market-Beating Return Is Disappearing
Bloomberg · 05/10 04:08
Biotech Fund Wipes Out Last of Its Gains Since Covid Started
Bloomberg · 05/09 20:23
BlackRock Is Killing Off Two of Its Best-Performing Mexico ETFs
Bloomberg · 05/09 17:03
Cash Is the Only Winner in a Market Gripped by Stagflation Fear
Bloomberg · 05/09 14:51
Dictator’s Son Marcos Jr. Set for Big Win in Philippine Election
Bloomberg · 05/09 13:58
More
No Data
Learn about the latest financial forecast of CNCR. Analyze the recent business situations of Loncar Cancer Immunotherapy ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
04/30/2022
3 Year
Lipper Fund
04/30/2022
5 Year
Lipper Fund
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-42.3700%
--
1-Month
-15.3147%
--
3-Month
-20.2982%
--
6-Month
-44.5980%
--
1-Year
-48.2225%
--
3-Year
-21.3113%
--
5-Year
-27.5527%
--
No Data
No Data
No Data
Profile
Fund Name
Loncar Cancer Immunotherapy ETF
Inception Date
2015-10-14
Benchmark
Russell 2000 TR
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Wen/Zayas